← Back to Patent Explorer
US3818014A Expired / Lapsed US ⏱️ 0.0 years remaining

2-quinolyl-4(5)-trifluoromethylimidazoles

Assignee: Merck and Co Inc
•
Filing: 1972-06-21
•
Granted: 1974-06-18
•
Expires: 1992-06-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 4(5)-Trifluoromethylimidazoles having optional substituents in the 1 and 2 positions are provided. The novel 4(5)trifluoromethylimidazoles are prepared by reacting a 1,1-dihalo3,3,3-trifluoroacetone compound with an appropriate carboxaldehyde and ammonia. The 4(5)-trifluoromethylimidazoles are useful as anti-gout and anti-hyperuricemic agents.

Inventors

  • 👤 J Baldwin
  • 👤 F Novello

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 08:12
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/64; C07D233/66; C07D233/91; C07D233/92; C07D233/93; C07D233/94; C07D233/95

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 5 words
A compound of the formula:
Claim 2
Dependent Claim 1 words
2-(2-Quinolyl)-4(5)-trifluoromethylimidazole.
Claim 3
Dependent Claim 1 words
2-(6-Quinolyl)-4(5)-trifluoromethylimidazole.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-06-17 1977-12-17 1978-06-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-06-17 1981-12-17 1982-06-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-06-17 1985-12-17 1986-06-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag